Strategic partnerships Ventri Health recently partnered with A&M Biomedical Inc, presenting an opportunity to co-sell or integrate solutions with a collaborator in the medical device/biomedical space, expanding channel reach and joint go-to-market efforts.

Clinical leadership Appointment of renowned cardiologists to the Clinical Advisory Board signals a focus on clinical credibility and expert-backed validation, which can be leveraged to engage hospitals and health systems seeking evidence-driven cardio diagnostics and outpatient management tools.

Digital footprint Renovated website launch and ongoing digital presence, paired with a robust tech stack, suggests investment in online marketing and educational content that sales teams can leverage for lead generation, product demonstrations, and customer onboarding.

FDA-cleared edge Vivio System is FDA-cleared for non-invasive LVEDP measurement in outpatient settings, presenting a clear value proposition for health systems aiming to reduce invasive procedures, lower costs, and improve patient care.

Market position With mid-market size and revenue in the multi-million range, Ventric Health sits between smaller digital health players and larger incumbents, offering a potentially fast-moving path to expanded deployments within value-based care organizations and cardiovascular programs.